menu
    • menu

    Company profile for Clene Nanomedicine

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Clene has a new vision for a pharmaceutical future using therapeutic elements in clean, new nanoforms. Our patented Clean-Surface Nanosuspension™ (CSN) technology produces clean-surface nanocrystals at commercially viable rates. By coupling high-purity metallic donor materials with high-purity water, CSN unlocks the potential of therapeutic nanoparticles and represents a clean break from the standard paradigm of small-mole...
    Clene has a new vision for a pharmaceutical future using therapeutic elements in clean, new nanoforms. Our patented Clean-Surface Nanosuspension™ (CSN) technology produces clean-surface nanocrystals at commercially viable rates. By coupling high-purity metallic donor materials with high-purity water, CSN unlocks the potential of therapeutic nanoparticles and represents a clean break from the standard paradigm of small-molecule drugs and large-molecule biologics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clene NanomedicineUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3165 East Millrock Drive, Suite 325 Salt Lake City, Utah 84121
    Telephone
    Telephone
    1-801-676-9695
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://clene.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clene-nanomedicine
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clene Reveals 2025 Financials And Operating Highlights
    Clene Reveals 2025 Financials And Operating Highlights

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254582/0/en/Clene-Reports-Full-Year-2025-Financial-Results-and-Recent-Operating-Highlights.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Clene Highlights Stockholder Letter On Cnm-Au8 2026 Catalysts
    Clene Highlights Stockholder Letter On Cnm-Au8 2026 Catalysts

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243459/0/en/Clene-Issues-Stockholder-Letter-Highlighting-Upcoming-CNM-Au8-2026-Catalysts.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Clene To Present At The Emerging Growth Conference
    Clene To Present At The Emerging Growth Conference

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241096/0/en/Clene-to-Present-at-the-Emerging-Growth-Conference.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Clene To Present At The Emerging Growth Conference
    Clene To Present At The Emerging Growth Conference

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220319/0/en/Clene-to-Present-at-the-Emerging-Growth-Conference.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Clene Reveals Cnm-Au8 Biomarker Data Backing NDA For FDA Meeting
    Clene Reveals Cnm-Au8 Biomarker Data Backing NDA For FDA Meeting

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216909/0/en/Clene-Announces-Additional-CNM-Au8-Biomarker-Data-Supporting-Potential-NDA-Filing-for-Upcoming-In-Person-FDA-Meeting.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Clene Announces Registered Direct Offering Of Over $28 Million
    Clene Announces Registered Direct Offering Of Over $28 Million

    09 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/09/3216087/0/en/Clene-Announces-Registered-Direct-Offering-of-Over-28-Million.html

    GLOBENEWSWIRE
    09 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search